Singapore, May 6 -- Bhubaneswar-based medtech startup EzeRx, founded in 2018, has developed an easy, painless and non-invasive screening solution to identify primary health parameters at an early stage such as ailments in liver, kidney, lungs and blood glucose level and common problems like anaemia, in less than a minute without withdrawing blood from the human body. With support from promoters like Mankind Pharma, this startup has set big plans for expansion in the medtech and diagnostic market in India and abroad. BioSpectrum spoke in detail with Partha Pratim Das, Chief Executive Officer, EzeRx about the startups's growth plans.

What major plans are in store for the company in FY 24-25?

In FY 24-25, EzeRx has significant plans for bo...